Director’s Commitment to Continuous Improvement Drives Quality Culture
March 10, 2022
As Quality Director for RTI Surgical's Alachua facility, Rose Lopez is an influential cross-functional leader whose commitment to excellence and continuous improvement drive RTI’s quality culture. Rose has served as Quality Director since 2021, overseeing the Quality Systems, Quality Assurance, Biomedical Lab and Supplier Quality teams responsible for maintaining RTI’s robust Quality Assurance program. Rose and her team ensure compliance with applicable state, federal and international regulations and implement industry best practices to deliver superior quality to customers.
“Rose believes in excellence and will not accept things that are done without due consideration. She cares as much about my team’s success as she does her team’s success, which is rare, but an essential quality for a good leader,” said Catisha Turner, Alachua Plant Director.
In her role, Rose demonstrates a genuine commitment to quality by holding others accountable for prioritizing quality in all actions and decisions. She cares about her team and creates a supportive environment that boosts employee morale. Her focus and work ethic are second to none, and she brings her best to the job every day to produce the best results for the patients who receive RTI’s implants.
“I'm continuously impressed by the determination and passion in Rose's daily approach to work. She demonstrates an unwavering commitment to quality and continuous improvement which is an example for everyone around her,” said Matt Crump, Vice President of Donor Services & Operations.
As a result of her experience and organizational influence, she was selected to represent RTI’s Tissue & Biologics business at the 2021 Montagu Future Leaders Forum in London. The forum, designed to inspire and develop employees with strong talent, explored change leadership and provided an opportunity to learn, share common challenges and find new solutions together.
After gaining extensive experience in product and process development in the pharmaceutical, biologics and medical device industries, Rose joined RTI in 2015 as a Quality Engineer for Bone Graft Substitutes. She was quickly promoted through the quality organization, serving as a Sterility Assurance Manager before being promoted again to lead the Research & Development design transfer group responsible for process development activities.
Rose started her career at Nephron Pharmaceuticals as a Microbiology Analyst before moving into a Quality Control Manager role at TissueNet, where she later gained experience in product development. Rose earned a Bachelor of Arts in Cell and Molecular Biology from Hofstra University and speaks three languages. She enjoys spending time with her daughter, her husband and their dog Vader.
“I am extremely grateful to have Rose as a part of my team. Her drive, passion and commitment to leading and fostering RTI through our ongoing journey and transformation is a benefit to the entire organization. RTI is lucky to have Rose as a leader who is positively impacting the company,” said Amanda LoGuidice, Vice President of QA/RA & Product Science.